Lung Cancer

2018 World Conference on Lung Cancer: 8 Key Findings

2018 World Conference on Lung Cancer: 8 Key Findings

In September, health experts from around the globe gathered at the 2018 World Conference on Lung Cancer in Toronto. We compiled a list of 8 key findings presented at the event.

Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day

Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day

Mean changes in hematologic indices found similar regardless of same-day or prior administration of B12 supplementation in patients receiving pemetrexed for NSCLC or pleural mesothelioma.

Checkpoint Inhibitor Pneumonitis in NSCLC

Checkpoint Inhibitor Pneumonitis in NSCLC

Immune checkpoint inhibitor pneumonitis is a potentially serious complication that may occur more in patients with lung cancer than previously suspected.

Models Project 79% Drop in Lung CA Mortality by 2065

Models Project 79% Drop in Lung CA Mortality by 2065

Annual number of deaths expected to continue to decrease despite growth, aging of US population.

Angiotensin-Converting Enzyme Inhibitors May Increase Lung Cancer Risk

Angiotensin-Converting Enzyme Inhibitors May Increase Lung Cancer Risk

The use of angiotensin-converting enzyme inhibitors is associated with an increased risk for lung cancer compared with angiotensin receptor blockers.

Open Surgery for Early Lung Cancer Tied to Long-Term Opioid Use

Open Surgery for Early Lung Cancer Tied to Long-Term Opioid Use

Surgical invasiveness might play a role in the odds of becoming a long-term opioid user after early-stage lung cancer surgery.

Prediction tool helps tailor lung cancer screening to patient benefit and preferences

Prediction tool may help physicians better personalize screening discussions with patients.

Lung Cancer Incidence Higher for Young Women Than Young Men

Lung Cancer Incidence Higher for Young Women Than Young Men

Crossover in sex-specific rates among US non-Hispanic whites born since 1965

Multi-analyte blood test detects 8 common cancers

Multi-analyte blood test detects 8 common cancers

A multi-analyte blood test, CancerSEEK, can detect 8 common cancer types, with high sensitivity and specificity.

Nivolumab treatment for lung cancer may successfully deplete HIV reservoirs

Nivolumab treatment for lung cancer may successfully deplete HIV reservoirs

Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir.

Vitamin B supplements not chemopreventive for lung cancer

Vitamin B supplements not chemopreventive for lung cancer

By

Vitamin B supplements are not chemopreventive and may increase cancer risk in men.

Consuming total, saturated fat increases the risk of lung cancer

Consuming total, saturated fat increases the risk of lung cancer

The risk of lung cancer was reduced for high intake of polyunsaturated fat.

VA lung cancer screening program finds high rate of incidental findings, low cancer detection rate

VA lung cancer screening program finds high rate of incidental findings, low cancer detection rate

By

An estimated 900,000 veterans of a population of 6.7 million VHA patients met the criteria for LCS.

Nivolumab versus docetaxel in patients with advanced squamous cell non-small cell lung cancer

Nivolumab versus docetaxel in patients with advanced squamous cell non-small cell lung cancer

By

Recent studies show that nivolumab was associated with increased overall survival rate when compared to docetaxel in patients with advanced squamous cell non-small cell lung cancer.

More incidental pulmonary nodules result from increased scanning

More incidental pulmonary nodules result from increased scanning

The number of incidental pulmonary nodules has increased though the number of lung cancer cases remained stable.

Medicare proposes to cover lung cancer screenings for at-risk patients

Medicare proposes to cover lung cancer screenings for at-risk patients

CMS announced it has drafted a reimbursement proposal to cover annual computed tomography (CT) scans for high-risk patients.

Experts weigh risks, benefits of lung cancer screening for seniors

Experts weigh risks, benefits of lung cancer screening for seniors

The government is evaluating the risks and benefits associated with low-dose CT scans and potential coverage changes for Medicaid patients.

Lung cancer screening cost-effective for Medicare beneficiaries

Lung cancer screening cost-effective for Medicare beneficiaries

Low-dose computed tomography screening is a low-cost strategy that can help the estimated 4.9 million Medicare patients that could meet criteria for lung cancer.

Lung cancer screening connected to smoking cessation

Lung cancer screening connected to smoking cessation

Further research into smoking cessation within screening programs may continue to decrease smoking rates.

FDA approves Zykadia for metastatic NSCLC

FDA approves Zykadia for metastatic NSCLC

The FDA has granted accelerated approval to Zykadia (ceritinib) in patients with metastatic ALK-positive non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

USPSTF: Screen high-risk adults for lung cancer

USPSTF: Screen high-risk adults for lung cancer

Screening urged for adults aged 55 to 80 years with 30 pack-year history who smoke or recently quit

Sign Up for Free e-newsletters